# Spironolactone for the Treatment of Melasma

> **NCT03953209** · PHASE1 · WITHDRAWN · sponsor: **Medical University of South Carolina**

## Conditions studied

- Melasma

## Interventions

- **DRUG:** Spironolactone 50Mg Tablet
- **DRUG:** Spironolactone 100Mg Tablet
- **DRUG:** Spironolactone 200Mg

## Key facts

- **NCT ID:** NCT03953209
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03-05
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Conflict with funding
- **Last updated:** 2024-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03953209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03953209, "Spironolactone for the Treatment of Melasma". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT03953209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*